The benefits of exercise for patients with non-alcoholic fatty liver disease.
As exercise is now an established therapy for the management of non-alcoholic fatty liver disease (NAFLD), recent investigations have sought to identify the optimal dose (type, intensity and amount) of exercise for hepatic benefit. Here, the authors discuss the following: the role of aerobic exercise for the modulation of hepatic steatosis; the limited evidence for the role of resistance training in reducing liver fat; the lack of evidence from clinical trials on the role of exercise in non-alcoholic steatohepatitis; and the benefits of exercise for patients with NAFLD, beyond steatosis. Based on current evidence, the authors provide recommendations for exercise prescription for patients with NAFLD.
a 1 Centre for Research on Exercise, Physical Activity and Health, School of Human Movement and Nutrition Sciences, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Shelley E
SE
Keating
b 2 Storr Liver Centre, Westmead Millennium Institute and Westmead Hospital, University of Sydney, NSW, Australia.
Jacob
J
George
c 3 Discipline of Exercise and Sport Science, Faculty of Health Sciences, University of Sydney, NSW, Australia.|d 4 Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Sydney Medical School, University of Sydney, NSW, Australia.
Nathan A
NA
Johnson
D015444:Exercise / Q000502:physiology*; D005081:Exercise Therapy; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000628:therapy*; D005082:Physical Exertion / Q000502:physiology; D017410:Practice Guidelines as Topic; D055070:Resistance Training
aerobic training; exercise; hepatic steatosis; non-alcoholic fatty liver disease; resistance training